node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
IGFBP3 | LOC101162674 | ENSORLP00000021459 | ENSORLP00000045746 | Insulin like growth factor binding protein 3. | Insulin-like growth factor binding protein 3. | 0.902 |
IGFBP3 | LOC101163560 | ENSORLP00000021459 | ENSORLP00000029312 | Insulin like growth factor binding protein 3. | Tyrosine-protein kinase receptor. | 0.487 |
IGFBP3 | LOC101173298 | ENSORLP00000021459 | ENSORLP00000030267 | Insulin like growth factor binding protein 3. | Tyrosine-protein kinase receptor. | 0.411 |
IGFBP3 | igf1 | ENSORLP00000021459 | ENSORLP00000026564 | Insulin like growth factor binding protein 3. | Insulin-like growth factor 1. | 0.913 |
LOC100125446 | LOC101158510 | ENSORLP00000034276 | ENSORLP00000025001 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Eph receptor A2 b. | 0.722 |
LOC100125446 | LOC101163560 | ENSORLP00000034276 | ENSORLP00000029312 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Tyrosine-protein kinase receptor. | 0.979 |
LOC100125446 | LOC101166254 | ENSORLP00000034276 | ENSORLP00000043238 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Tyrosine-protein kinase receptor. | 0.979 |
LOC100125446 | LOC101172253 | ENSORLP00000034276 | ENSORLP00000044694 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.902 |
LOC100125446 | LOC101173298 | ENSORLP00000034276 | ENSORLP00000030267 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Tyrosine-protein kinase receptor. | 0.979 |
LOC100125446 | LOC101174210 | ENSORLP00000034276 | ENSORLP00000041353 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Protein kinase domain-containing protein. | 0.731 |
LOC100125446 | igf1 | ENSORLP00000034276 | ENSORLP00000026564 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin-like growth factor 1. | 0.912 |
LOC100125446 | met | ENSORLP00000034276 | ENSORLP00000024532 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | MET proto-oncogene, receptor tyrosine kinase. | 0.746 |
LOC101158510 | LOC100125446 | ENSORLP00000025001 | ENSORLP00000034276 | Eph receptor A2 b. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.722 |
LOC101158510 | LOC101172253 | ENSORLP00000025001 | ENSORLP00000044694 | Eph receptor A2 b. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.722 |
LOC101158510 | igf1 | ENSORLP00000025001 | ENSORLP00000026564 | Eph receptor A2 b. | Insulin-like growth factor 1. | 0.656 |
LOC101162674 | IGFBP3 | ENSORLP00000045746 | ENSORLP00000021459 | Insulin-like growth factor binding protein 3. | Insulin like growth factor binding protein 3. | 0.902 |
LOC101162674 | igf1 | ENSORLP00000045746 | ENSORLP00000026564 | Insulin-like growth factor binding protein 3. | Insulin-like growth factor 1. | 0.913 |
LOC101163560 | IGFBP3 | ENSORLP00000029312 | ENSORLP00000021459 | Tyrosine-protein kinase receptor. | Insulin like growth factor binding protein 3. | 0.487 |
LOC101163560 | LOC100125446 | ENSORLP00000029312 | ENSORLP00000034276 | Tyrosine-protein kinase receptor. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.979 |
LOC101163560 | LOC101166254 | ENSORLP00000029312 | ENSORLP00000043238 | Tyrosine-protein kinase receptor. | Tyrosine-protein kinase receptor. | 0.902 |